KIFC1 and neoplasm: These results provide new insight into mechanisms regarding how DNA damaging therapies always lead to CIN and therapeutic resistance, suggesting that targeting KIFC1 phosphorylation may provide new opportunities for reducing tumor metastasis and recurrence.